Lin H - Search Results

1

Species-specific susceptibility to cannabis-induced convulsions.

Whalley BJ, Lin H, Bell L, Hill T, Patel A, Gray RA, Elizabeth Roberts C, Devinsky O, Bazelot M, Williams CM, Stephens GJ. Whalley BJ, et al. Among authors: lin h. Br J Pharmacol. 2019 May;176(10):1506-1523. doi: 10.1111/bph.14165. Epub 2018 Mar 25. Br J Pharmacol. 2019. PMID: 29457829 Free PMC article.

2

Ca_V2.2 (N-type) voltage-gated calcium channels are activated by SUMOylation pathways.

Silveirinha VC, Lin H, Tanifuji S, Mochida S, Cottrell GS, Cimarosti H, Stephens GJ. Silveirinha VC, et al. Among authors: lin h. Cell Calcium. 2021 Jan;93:102326. doi: 10.1016/j.ceca.2020.102326. Epub 2020 Nov 30. Cell Calcium. 2021. PMID: 33360835

3

Analysis of the actions of the novel dopamine receptor-directed compounds (S)-OSU6162 and ACR16 at the D2 dopamine receptor.

Kara E, Lin H, Svensson K, Johansson AM, Strange PG. Kara E, et al. Among authors: lin h. Br J Pharmacol. 2010 Nov;161(6):1343-50. doi: 10.1111/j.1476-5381.2010.01010.x. Br J Pharmacol. 2010. PMID: 20804495 Free PMC article.

4

Conjugation of haloperidol to PEG allows peripheral localisation of haloperidol and eliminates CNS extrapyramidal effects.

Natfji AA, Nikitin DO, Semina II, Moustafine RI, Khutoryanskiy VV, Lin H, Stephens GJ, Watson KA, Osborn HMI, Greco F. Natfji AA, et al. Among authors: lin h. J Control Release. 2020 Jun 10;322:227-235. doi: 10.1016/j.jconrel.2020.02.037. Epub 2020 Feb 26. J Control Release. 2020. PMID: 32112855

5

CACHD1 is an α2δ-Like Protein That Modulates Ca_V3 Voltage-Gated Calcium Channel Activity.

Cottrell GS, Soubrane CH, Hounshell JA, Lin H, Owenson V, Rigby M, Cox PJ, Barker BS, Ottolini M, Ince S, Bauer CC, Perez-Reyes E, Patel MK, Stevens EB, Stephens GJ. Cottrell GS, et al. Among authors: lin h. J Neurosci. 2018 Oct 24;38(43):9186-9201. doi: 10.1523/JNEUROSCI.3572-15.2018. Epub 2018 Sep 4. J Neurosci. 2018. PMID: 30181139 Free PMC article.

6

Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor.

Lin H, Saisch SG, Strange PG. Lin H, et al. Br J Pharmacol. 2006 Oct;149(3):291-9. doi: 10.1038/sj.bjp.0706866. Epub 2006 Aug 21. Br J Pharmacol. 2006. PMID: 16921389 Free PMC article.

7

Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.

Haworth B, Lin H, Fidock M, Dorr P, Strange PG. Haworth B, et al. Among authors: lin h. Biochem Pharmacol. 2007 Sep 15;74(6):891-7. doi: 10.1016/j.bcp.2007.06.032. Epub 2007 Jun 26. Biochem Pharmacol. 2007. PMID: 17669370

8

Mechanisms of agonist action at D2 dopamine receptors.

Roberts DJ, Lin H, Strange PG. Roberts DJ, et al. Among authors: lin h. Mol Pharmacol. 2004 Dec;66(6):1573-9. doi: 10.1124/mol.104.004077. Epub 2004 Aug 31. Mol Pharmacol. 2004. PMID: 15340043

9

Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics.

Kara E, Lin H, Strange PG. Kara E, et al. Among authors: lin h. J Neurochem. 2010 Mar;112(6):1442-53. doi: 10.1111/j.1471-4159.2009.06554.x. Epub 2009 Dec 24. J Neurochem. 2010. PMID: 20050980 Free article.

10

Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor.

Vivo M, Lin H, Strange PG. Vivo M, et al. Among authors: lin h. Mol Pharmacol. 2006 Jan;69(1):226-35. doi: 10.1124/mol.105.012443. Epub 2005 Oct 4. Mol Pharmacol. 2006. PMID: 16204468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30,917 results

Search Page